iqvia semaglutide tirzepatide prescriptions q3 2024 Q1 2026: The Wegovy pill tilts the Novo Nordisk sentiment Newer Weight-Loss Drugs Not Cost-effective

Recent advances in monoclonal antibody therapies targeting A plaques (e.g., donanemab, lecanemab) have shown potential, but they also pose significant risks, such as amyloid-related imaging abnormalities with edema (ARIA-E), highlighting the need for safer and more effective alternatives

PSMA-based chimeric antigen receptor (CAR)-T cells therapy CAR-T cells are genetically engineered T cells that express an artificial T-cell receptor, endowing T-cell populations with the ability to target tumors independently of major histocompatibility-complex (MHC) engagement

Br J Radiol 92(1101):20180944

Our skill lies in matching each patient with the best possible treatment for their needs, to create a natural result

Initial benefits like improved sleep quality can often be noticed within the first one to two weeks